Happy New Year - Sunday Edition

Chips and dips

• Y2K revisited. Today a tech issue hit exchange servers on the Microsoft site which the company is rushing to try to fix before business resumes Monday.  Microsoft bought ATT's former V&R ad site. The share gained Friday but expect a reversal tomorrow.

• Qualcomm (QCOM), a US share that I own a lot of, gained 1.05% last week on higher expectations of sales.

• Meta (FB) missed its earnings forecast.

• Despite Elon Musk halting his selling, Tesla (TSLA) is still down.

Drugs mixed

• The rise in Bioline RX was based on a rumor that it was being bid for, which was not true. I sold ages ago.

• Alkermes of Ireland was downgraded to hold from buy and its eps estimate chopped to 12 cents from .174. 
• Biogen Idec fell 0.3% because China is cutting subsidies for electric cars and investors fear it will also chop the help given pharma. 

• Majors like Eli Lilly and Roche rose. Roche rose 0.5%. Eli Lilly gained 0.35%.

• British Glaxo steadily gained. 

• Pfizer went up because its Paxlovid covid-19 oral preventative for Covid-19 was approved by the UK and because it can be used to jab Moderna vets like us.

• Walgreen-Boots (WBA), the global drug store chain, was up on a rumour that Boots, its UK brand, is under offer from Bain Capital.

• Novacure was tipped by anonymous "Value Investor" on Seeking alpha. NVCR has been a loser last year.

• Novavax (NVAX) fell hard on news that its long-delayed covid-19 jab will be under US FDA scrutiny later this month. There is fear its problems are not resolved.

• Grifols lost another 1.32% but then recovered by 1%.

• Dr Reddy's is up. Any mess in India leads to demand for drugs; even a New Year's riot at a Hindu temple which led to deaths from trampling. 

AZN continued its rise. 

• Johnson & Johnson stock (JNJ) is being moved by the spinoff of its consumer product line. This includes OTC drugs but mostly other products like cosmetics and toilet paper.

• US share Medtronic (MDT) fell on an FDA warning on the security of its Northridge (Cal) plant. It is hard to square this sloppiness when the operation is in the USA.

Caught In Traffic

• Nio delivered 10,489 electric vehicles in Dec., a rise from last Dec. of barely under 50%. That's the good news. The bad news is that the People's Republic of China is cutting its electric vehicle subsidies starting with a 30% cut later this year. And that NIO Dec. deliveries were lower than those in Nov.

• Tesla has recalled a half-million cars.

• Cameco (CCJ), a green energy firm, is up fractionally. 


• Antofagasta rose despite the lefty winner in Chile where it mines rare earths. Royal Bank of Canada exited its shares which were owned by the funds it manages. The stock rose because RBC is considered to be a weak hand. The rise may mean that there will be talks and a deal.

• Gold has been my worst idea for 2021 but who knows what is coming this year.

• I also have hopes for UUUU.


How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.